Buclizine HCl
CAS No. 129-74-8
Buclizine HCl ( —— )
Catalog No. M17929 CAS No. 129-74-8
Buclizine HCl is the hydrochloride salt form of buclizine, a piperazine histamine H1 receptor antagonist with primarily antiemetic and antivertigo activities.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
50MG | 27 | In Stock |
|
100MG | 38 | In Stock |
|
200MG | 50 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBuclizine HCl
-
NoteResearch use only, not for human use.
-
Brief DescriptionBuclizine HCl is the hydrochloride salt form of buclizine, a piperazine histamine H1 receptor antagonist with primarily antiemetic and antivertigo activities.
-
DescriptionBuclizine HCl is the hydrochloride salt form of buclizine, a piperazine histamine H1 receptor antagonist with primarily antiemetic and antivertigo activities. Buclizine binds to and blocks the histamine H1 receptor, thereby preventing the symptoms that are caused by histamine activity. Buclizine exerts its anti-emetic effect by binding to and blocking the muscarinic and histamine receptors in the vomiting center of the central nervous system (CNS). This may prevent activation of the chemoreceptor trigger zone (CTZ) and may reduce nausea and vomiting.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorHT; Cholinergic
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number129-74-8
-
Formula Weight505.95
-
Molecular FormulaC28H33ClN2·2HCl
-
Purity98%
-
Solubility——
-
SMILESCC(C)(C)c1ccc(cc1)CN1CCN(CC1)C(c1ccccc1)c1ccc(cc1)Cl.Cl.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Mostafa GA, et al. Profiles Drug Subst Excip Relat Methodol, 2011, 36:1-33.
molnova catalog
related products
-
Kinetensin
Kinetensin is a neurotensin-like peptide.
-
Afrormosine
Afrormosine is a natural product.
-
(S,R,S)-AHPC-PEG2-NH...
(S,R,S)-AHPC-PEG2-NH2 (VH032-PEG2-NH2) is a synthesized E3 ligase ligand-linker conjugate that incorporates the (S,R,S)-AHPC based VHL ligand and 2-unit PEG linker used in the synthesis of PROTACs.